Artivion | CRY - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Abbott USD 52.06B 69M 2026-03
Accuray USD 53.42M 8.45M 2025-12
AngioDynamics USD 176.33M 2.52M 2025-09
Artivion USD 450.47M 2.24M 2026-03
AtriCure USD 491.69M 242K 2026-03
Baxter International USD 6.04B 86M 2026-03
Becton, Dickinson and Co. USD 24.13B 1.15B 2026-03
Boston Scientific USD 25.86B 1.63B 2026-03
Edwards Lifesciences USD 10.33B 10.1M 2026-03
Inogen USD 197.18M 2.32M 2025-09
Integra LifeSciences USD 1.04B 1.06M 2026-03
J&J USD 81.19B 358M 2026-03
Mesa Laboratories USD 186.69M 8.22M 2025-12
Orthofix International USD 435.19M 14.85M 2026-03
Pfizer USD 90.1B 3.63B 2026-03
ResMed USD 6.49B 171.03M 2026-03
Stryker USD 22.42B 635M 2025-12
Tandem Diabetes Care USD 132.4M 22.77M 2026-03
Teleflex USD 3.08B 40.33M 2026-03
Terumo JPY 1.58T 62.18B 2026-03
Trinity Biotech USD -54.72M 5.18M 2025-09